CN Stock MarketDetailed Quotes

Jiangsu Kanion Pharmaceutical (600557)

Watchlist
  • 14.23
  • -0.23-1.59%
Trading Apr 24 13:29 CST
8.06BMarket Cap26.50P/E (TTM)

Jiangsu Kanion Pharmaceutical (600557) Key Financial Indicators

600557 Earnings per Share (EPS)

According to the latest financial report of Jiangsu Kanion Pharmaceutical, the latest earnings per share (TTM) for the company is 0.54. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: CNY

Cumulative Quarterly

Loading...

600557 Book Value Per Share (BVPS)

Analyzing a company's fundamentals? Check out Jiangsu Kanion Pharmaceutical's latest financial report to see how much their book value per share (BVPS) is currently at 8.51.

Currency: CNY

Cumulative Quarterly

Loading...

600557 Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Jiangsu Kanion Pharmaceutical shows that the company's current ratio is 1.92, indicating healthy liquidity.

Currency: CNY

Cumulative Quarterly

Loading...

600557 Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Jiangsu Kanion Pharmaceutical, the quick ratio is 1.66, indicating that the company can meet its short-term debt obligations.

Currency: CNY

Cumulative Quarterly

Loading...

600557 Return on Equity (ROE)

Want to learn more about the financial health of Jiangsu Kanion Pharmaceutical? The latest ROE figure is 6.51%, indicating that the company has stable profitability.

Currency: CNY

Cumulative Quarterly

Loading...

600557 Return on Assets (ROA)

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Jiangsu Kanion Pharmaceutical, the total asset return on investment (ROA) is 4.46%.

Currency: CNY

Cumulative Quarterly

Loading...

600557 Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check Jiangsu Kanion Pharmaceutical's latest financial report to see how their gross margin is doing - currently at 71.44%.

Currency: CNY

Cumulative Quarterly

Loading...

600557 Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Jiangsu Kanion Pharmaceutical, the net profit margin is 9.33%, which is a good sign for its profitability.

Currency: CNY

Cumulative Quarterly

Loading...

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
At midnight Beijing time on April 24, Iranian Parliament Speaker Kalibaf announced his withdrawal from the Iran-US negotiation delegation. M Show More